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The y-aminobutyric acid (GABAA) receptor is part of a supramolecular complex which is responsible for gating a chloride channel in the brain.1} Several different classes of compounds interact with this complex, e.g. 1 ,4-benzodiazepines, barbiturates, some steroids, and f-butylbicyclophosphorothionate (TBPS). The convulsant picrotoxin2) and the diterpenes carnosol and carnosic acid3) bind to the same site as TBPS. In a search for fungal metabolites that bind to the TBPSsite, extracts of more than 100 species were screened for their ability to inhibit 35S-TBPS binding to a rat brain membrane homogenate preparation (unpublished results), with a sensitive radio-ligand assay.40
One of the most potent extracts was obtained from a Fusarium species, and bioassay-guided fractionation yielded four active components. These were analysed by high field NMR and mass spectroscopy, and found to be identical5* to enniatin A (1), Al (2), Bl (3) and B (4) (see Fig. 1 for structures). The IC50 values for the inhibition of the binding of 35S-TBPSto rat cortical membranes in vitro for the four compoundsare given in Table 1 . Enniatin A (1) is the most potent of the four while enniatin B (4) only induced 20% inhibition at the highest concentration tested (40 /xg/ml). In order to investigate the selectivity of enniatin A (1) it was assayed for the inhibition of the binding of ligands that bind to other receptors (see Table 2 ). At the This finding, together with the fact that the potency of the compounds is rather low, indicate that the effect of the enniatins may result from non-specific membrane disruption.
Besides the non-specific membrane activity reported in this paper, the enniatins possess a number of bioactivities,6) similar to other cyclodepsipeptides such as the destruxins and valinomycin.7) concentrations divided by a factor of2 up to 40 jug/ml, single estimations. 3) 
